Skip to main content

Epidermolysis Bullosa Acquisita

  • Chapter
Clinical and Basic Immunodermatology
  • 2465 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Roenigk HH, et al. Epidermolysis bullosa acquisita: Report of three cases and review of all published cases. Arch Dermatol 1971;103:10.

    Google Scholar 

  2. Kushniruk W. The immunopathology of epidermolysis bullosa acquisita. Can Med Assoc J 1973;108:1143.

    PubMed  CAS  Google Scholar 

  3. Gibbs RB, Minus HR. Epidermolysis bullosa acquisita with electron microscopical studies. Arch Dermatol 1975;111:215.

    Article  PubMed  CAS  Google Scholar 

  4. Nieboer C, et al. Epidermolysis bullosa acquisita: Immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients. Br J Dermatol 1980;102:383.

    Article  PubMed  CAS  Google Scholar 

  5. Yaoita H, et al. Epidermolysis bullosa acquisita: Ultrastructural and immunological studies. J Invest Dermatol 1981;76:288.

    Article  PubMed  CAS  Google Scholar 

  6. Gammon WR, et al. Epidermolysis bullosa acquisita: a pemphigoid-like disease. J Am Acad Dermatol 1984;11:820.

    Article  PubMed  CAS  Google Scholar 

  7. Dahl MGC. Epidermolysis bullosa acquisita: a sign of cicatricial pemphigoid? Br J Dermatol 1979;101:475.

    Article  PubMed  CAS  Google Scholar 

  8. Richter BJ, McNutt NS. The spectrum of epidermoly-sis bullosa acquisita. Arch Dermatol 1979;115:1325.

    Article  PubMed  CAS  Google Scholar 

  9. Provost TT, et al. Unusual sub-epidermal bullous diseases presenting as an inflammatory bullous disease. Arch Dermatol 1979;115:156.

    Article  PubMed  CAS  Google Scholar 

  10. Woodley DT. Epidermolysis bullosa acquisita. Prog Dermatol 1988;22:1.

    Google Scholar 

  11. Kurzhals G, et al. Acquired epidermolysis bullosa with the clinical features of Brunsting-Perry cicatricial bullous pemphigoid. Arch Dermatol 1991;127:391.

    Article  PubMed  CAS  Google Scholar 

  12. Woodley DT, et al. Identification of the skin basement membrane autoantigen in epidermolysis bul-losa acquisita. N Engl J Med 1984;310:1007.

    PubMed  CAS  Google Scholar 

  13. Woodley DT, et al. The epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest 1988;81:683.

    Article  PubMed  CAS  Google Scholar 

  14. Ray TL, et al. Epidermolysis bullosa acquisita and inflammatory bowel disease. J Am Acad Dermatol 1982;6:242.

    Article  PubMed  CAS  Google Scholar 

  15. Christiano AM, et al. A common insertion mutation in COLA1 in two Italian families with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 1996;106:679.

    Article  PubMed  CAS  Google Scholar 

  16. Parente MG, et al. Human type VII collagen: cDNA cloning and chromosomal mapping of the gene. Proc Natl Acad Sci USA 1991;88:6931.

    Article  PubMed  CAS  Google Scholar 

  17. Shimizu H. Molecular basis of recessive dystrophic epidermolysis bullosa: Genotype/phenotype correlation in a case of moderate clinical severity. J Invest Dermatol 1996;106:119.

    Article  PubMed  CAS  Google Scholar 

  18. Woodley DT, et al. Burn wounds resurfaced by cultured epidermal autografts show abnormal recon-stitution of anchoring fibrils. JAMA 1988;259:2566.

    Article  PubMed  CAS  Google Scholar 

  19. Lapiere J-C, et al. Epitope mapping of type VII collagen: Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest 1993;92:1831.

    Article  PubMed  CAS  Google Scholar 

  20. Jones DA, et al. Immunodominant autoepitopes of type VII collagen are short, paired peptide sequences within the fibronectin type III homology region of the non-collagenous (NC1) domain. J Invest Dermatol 1995;104:231.

    Article  PubMed  CAS  Google Scholar 

  21. Woodley DT, et al. Specific affinity between fibronec-tin and the epidermolysis bullosa acquisita antigen. J Clin Invest 1987;179:1826.

    Article  Google Scholar 

  22. Lapiere J-C, et al. Type VII collagen specifically binds fibronectin via a unique subdomain within the collagenous triple helix. J Invest Dermatol 1994;103:637.

    Article  PubMed  CAS  Google Scholar 

  23. Chen M, et al. Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. J Biol Chem 1997;272:14516.

    Article  PubMed  CAS  Google Scholar 

  24. Gammon WR, et al. Evidence that antibasement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermoly-sis bullosa acquisita autoantigens. J Invest Dermatol 1985;84:472.

    Article  PubMed  CAS  Google Scholar 

  25. Barradori L, et al. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice. Arch Dermatol 1995;131:590.

    Article  Google Scholar 

  26. Gammon WR, et al. Increased frequency of HLA DR2 in patients with autoantibodies to EBA antigen: Evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated. J Invest Dermatol 1988;91:228.

    Article  PubMed  CAS  Google Scholar 

  27. Stewart MI, Woodley DT. Acquired epidermoly-sis bullosa and associated symptomatic esophageal webs. Arch Dermatol 1991;127:373.

    Article  PubMed  CAS  Google Scholar 

  28. Park SB, et al. Epidermolysis bullosa acquisita in childhood: a case mimicking chronic bullous derma-tosis of childhood. Clin Exp Dermatol 1997;22:220.

    Article  PubMed  CAS  Google Scholar 

  29. Callot-Mellot C, et al. Epidermolysis bullosa acquisita in childhood. Arch Dermatol 1997;133:1122.

    Article  PubMed  CAS  Google Scholar 

  30. Hashimoto T, et al. A case of linear IgA bullous der-matosis with IgA anti-type VII collagen autoantibod-ies. Br J Dermatol 1996;134:336.

    Article  PubMed  CAS  Google Scholar 

  31. Bauer JW, et al. Ocular involvement in IgA-epidermo-lysis bullosa acquisita. Br J Dermatol 1999;141:887.

    Article  PubMed  CAS  Google Scholar 

  32. Lee CW. Serum IgA autoantibodies in patients with epidermolysis bullosa acquisita: a high frequency of detection. Dermatology 2000;200:83.

    Article  PubMed  CAS  Google Scholar 

  33. Edwards S, et al. Bullous pemphigoid and epidermo-lysis bullosa acquisita: presentation, prognosis and immunopathology in 11 children. Pediatr Dermatol 1998;15:184.

    Article  PubMed  CAS  Google Scholar 

  34. Burke WA, et al. Epidermolysis bullosa acquisita in a patient with multiple endocrinopathies syndrome. Arch Dermatol 1986;122:187.

    Article  PubMed  CAS  Google Scholar 

  35. Chan L, Woodley DT. Pemphigoid: bullous and cica-tricial. In: Lichtenstein LM, Fauci AS, eds. Current Therapy in Allergy, Immunology and Rheumatology, 5th ed. St. Louis: Mosby, 1996:93.

    Google Scholar 

  36. Fine JD, et al. The presence of intra-lamina lucida blister formation in epidermolysis bullosa acquisita: possible role of leukocytes. J Invest Dermatol 1989;92:27.

    Article  PubMed  CAS  Google Scholar 

  37. Briggaman RA, et al. Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes. J Exp Med 1984;160:1027.

    Article  PubMed  CAS  Google Scholar 

  38. Woodley DT, et al. Localization of basement membrane components after dermal-epidermal junction separation. J Invest Dermatol 1983;81:149.

    Article  PubMed  CAS  Google Scholar 

  39. Gammon WR, et al. Differentiating anti-lamina luc-ida and antisublamina dense anti-BMZ antibodies by direct immunofluorescence on 1.0 M sodium chloride separated skin. J Invest Dermatol 1983;84:215.

    Google Scholar 

  40. Domloge-Hultsch N, et al. Antiepiligrin cicatricial pemphigoid: a subepithelial bullous disorder. Arch Dermatol 1994;130:1521.

    Article  PubMed  CAS  Google Scholar 

  41. Chan LS, et al. A newly identified 105-kDa lower lamina lucida autoantigen is an acidic protein distinct from the 105-kDa gamma 2 chain of laminin 5. J Invest Dermatol 1995;105:75.

    Article  PubMed  CAS  Google Scholar 

  42. Ceilley E, et al. Labeling of fractured human skin with antibodies to BM 600/nicein, epiligrin, kalinin and other matrix components. J Dermatol Sci 1993;5:97.

    Article  PubMed  CAS  Google Scholar 

  43. Ghohestani RF, et al. The a5 chain of type IV collagen is the target of IgG autoantibodies in a novel autoimmune disease with subepidermal blisters and renal insufficiency. J Biol Chem 2000;275:16002.

    Article  PubMed  CAS  Google Scholar 

  44. Gammon WR, et al. Direct immunofluorescence studies of sodium chloride—separated skin in the differential diagnosis of bullous pemphigoid and epi-dermolysis bullosa acquisita. J Am Acad Dermatol 1990;22:664.

    Article  PubMed  CAS  Google Scholar 

  45. Woodley DT, et al. Epidermolysis bullosa acquisita antigen, a new major component of cutaneous basement membrane, is a glycoprotein with collagenous domains. J Invest Dermatol 1986;86:668.

    Article  PubMed  CAS  Google Scholar 

  46. Chen M, et al. Development of an ELISA for rapid detection of anti—type VII collagen autoantibodies in epidermolysis bullosa acquisita. J Invest Dermatol 1997;108:68.

    Article  PubMed  CAS  Google Scholar 

  47. Cunningham BB, et al. Colchicine for epidermolysis bullosa (EBA). J Am Acad Dermatol 1996;34:781.

    Article  PubMed  CAS  Google Scholar 

  48. Mekori YA, et al. Inhibition of delayed hyper-sensitivity reaction by colchicine: Colchicine inhibits interferon-gamma-induced expression of HLA-DR on an epithelial cell line. Clin Exp Immunol 1989;78:230.

    PubMed  CAS  Google Scholar 

  49. Connolly SM, Sander HM. Treatment of epidermo-lysis bullosa acquisita with cyclosporin. J Am Acad Dermatol 1987;16:890.

    Article  PubMed  CAS  Google Scholar 

  50. Crow LL, et al. Clearing of epidermolysis bullosa acquisita on cyclosporin A. J Am Acad Dermatol 1988;19:937.

    Article  PubMed  CAS  Google Scholar 

  51. Miller JL, et al. Remission of severe epidermolysis bullosa acquisita induced by extracorporeal photo-chemotherapy. Br J Dermatol 1995;133:467.

    Article  PubMed  CAS  Google Scholar 

  52. Gordon K, et al. Treatment of refractory epidermo-lysis bullosa acquisita with extracorporeal photoche-motherapy. Br J Dermatol 1997;136:415.

    Article  PubMed  CAS  Google Scholar 

  53. Meier F, et al. Epidermolysis bullosa acquisita: efficacy of high dose intravenous immunoglobulins. J Am Acad Dermatol 1993;29:334.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Burnett, J., Remington, J., Chen, M., Woodley, D.T. (2008). Epidermolysis Bullosa Acquisita. In: Gaspari, A.A., Tyring, S.K. (eds) Clinical and Basic Immunodermatology. Springer, London. https://doi.org/10.1007/978-1-84800-165-7_44

Download citation

  • DOI: https://doi.org/10.1007/978-1-84800-165-7_44

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84800-164-0

  • Online ISBN: 978-1-84800-165-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics